Next-Generation Probiotics and Their Metabolites in COVID-19
Since December 2019, a global pandemic has been observed, caused by the emergence of a new coronavirus, SARS CoV-2. The latter is responsible for the respiratory disease, COVID-19. The infection is also characterized by renal, hepatic, and gastrointestinal dysfunctions suggesting the spread of the v...
Main Authors: | Thomas Gautier, Sandrine David-Le Gall, Alaa Sweidan, Zohreh Tamanai-Shacoori, Anne Jolivet-Gougeon, Olivier Loréal, Latifa Bousarghin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/5/941 |
Similar Items
-
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitorsResearch in context
by: Laura Joachim, et al.
Published: (2023-11-01) -
<i>Roseburia intestinalis</i> Modulates PYY Expression in a New a Multicellular Model including Enteroendocrine Cells
by: Thomas Gautier, et al.
Published: (2022-11-01) -
Probiotics in the next-generation sequencing era
by: Jotham Suez, et al.
Published: (2020-01-01) -
Investiture of next generation probiotics on amelioration of diseases – Strains do matter
by: Tzu-Lung Lin, et al.
Published: (2019-12-01) -
Effect of Dietary Inclusion of Probiotic, Prebiotic and Butyric Acid Glycerides on Resistance against Coccidiosis in Broiler Chickens
by: Kamran Taherpour, et al.
Published: (2012-01-01)